Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Bausch Health Companies Inc (NY: BHC )

26.64 USD -0.04 (-0.16%)
Streaming Delayed Price Updated: 1:11 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Bausch Health Companies Inc

< Previous 1 2 3 4 5 6 7 Next >
Salix Supports Liver Awareness Month With New Educational Initiatives
Bausch Health Companies Inc. (NYSE/TSX: BHC) and its gastroenterology business, Salix Pharmaceuticals ("Salix"), one of the largest specialty pharmaceutical companies in the world committed to the... 
From PR Newswire
Nielsen's BASES Names LUMIFY® Eye Drops To 2020 U.S. BASES Top 25 Breakthrough Innovations List
Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced that BASES, a Nielsen Global Consumer business division, has named... 
From PR Newswire
FDA Approves Bausch + Lomb Alaway® Preservative Free (Ketotifen Fumarate) Ophthalmic Solution, 0.035%
First OTC Preservative-Free Eye Drop Approved for the Treatment of Itchy Eyes Associated with Allergies 
From PR Newswire
Bausch Health Announces VYZULTA® (Latanoprostene Bunod Ophthalmic Solution), 0.024%, is Now Approved In Seven Countries
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company"), Bausch + Lomb, a leading global eye health business, and Nicox (Euronext Paris: FR0013018124, COX), an international... 
From PR Newswire
BAUSCH HEALTH ANNOUNCES VYZULTA® (LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION), 0.024%, IS NOW APPROVED IN SEVEN COUNTRIES
From GlobeNewswire News Releases
Clearside Biomedical Announces Clinical Data Presentations at The Retina Society 2020 and Publication of XIPERE™ Data in Diabetic Macular Edema in Ophthalmology Retina
Presented the most robust aggregate dataset of suprachoroidal clinical injections demonstrating reliability and consistency of procedure 
From GlobeNewswire News Releases
Bausch Health Releases Annual Corporate Social Responsibility Report
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today released its annual Corporate Social Responsibility (CSR) Report, highlighting the Company's ongoing commitment to... 
From PR Newswire
Bausch Health And Alfasigma Announce Resolution Of XIFAXAN® Intellectual Property Litigation
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") along with its gastroenterology business, Salix Pharmaceuticals ("Salix"), which is one of the largest specialty... 
From PR Newswire
Bausch Health To Acquire Option To Purchase All Ophthalmology Assets Of Allegro Ophthalmics
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and Bausch + Lomb, its leading global eye health business, and Allegro Ophthalmics, LLC (Allegro), a privately held biopharmaceutical... 
From PR Newswire
Bausch Health Provides Company Update At 18th Annual Morgan Stanley Global Healthcare Conference
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced it has published a presentation that Joseph C. Papa, chairman and CEO, and Paul S. Herendeen, executive... 
From PR Newswire
Bausch Foundation Releases Inaugural Activity Report
Inaugural Report Outlines the Charitable Giving Efforts of Bausch Health 
From PR Newswire
Bausch Health To Participate At The 18th Annual Morgan Stanley Global Healthcare Conference
Bausch Health Companies Inc. (NYSE/TSX: BHC) today announced that Joseph C. Papa, chairman and CEO; Sam Eldessouky, senior vice president and corporate controller; and Arthur J. Shannon, senior vice... 
From PR Newswire
eToro Market Movers Healthcare Stocks: $ANTM $BHC $BMY
Tags The Market Signal
From The Market Signal
Sol-Gel Technologies Collaboration Partner Filed First-to-File Paragraph IV Certification for Duobrii®
From GlobeNewswire News Releases
Bausch Health To Reduce Debt By $100 Million Using Cash Generated From Operations
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced it will reduce debt by $100 million through the redemption of outstanding senior notes, using cash... 
From PR Newswire
Australia's TGA Approves BAUSCH + LOMB ULTRA® ONE DAY Silicone Hydrogel Daily Disposable Contact Lenses
Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced that it has received approval from Australia's Therapeutic Goods... 
From PR Newswire
Bausch + Lomb Launches Innovative Bausch + Lomb INFUSE™ Silicone Hydrogel (SiHy) Daily Disposable Contact Lenses
Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced the launch of Bausch + Lomb INFUSE™ silicone hydrogel (SiHy) daily... 
From PR Newswire
Health Canada Approves BAUSCH + LOMB ULTRA ONE DAY® Silicone Hydrogel Daily Disposable Contact Lenses
Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced that it has received approval from Health Canada for the sale of... 
From PR Newswire
Sol-Gel Technologies Reports Second Quarter 2020 Financial Results and Corporate Update
From GlobeNewswire News Releases
Bausch Health Companies Inc. Announces Second-Quarter 2020 Results
From PR Newswire
Bausch Health Announces Its Intention To Spin Off Its Eye Health Business Into An Independent Publicly Traded Company
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced that it intends to spin off its leading eye health business into an independent publicly traded entity... 
From PR Newswire
Bausch Health Resolves Canadian Securities Class Action
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company"), today announced that the parties in the Canadian securities class action (Cattuci et al. v. Valeant Pharmaceuticals... 
From PR Newswire
Bausch Health Resolves Legacy SEC Investigation
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company"), f/k/a Valeant Pharmaceuticals International, Inc. ("Valeant"), today announced the successful resolution of the legacy... 
From PR Newswire
Ortho Dermatologics Announces 2020 Aspire Higher Scholarship Recipients
Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses, today announced the recipients of... 
From PR Newswire
Bausch Health Companies Inc. Will Release Second-Quarter 2020 Financial Results On August 6
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") will release its second-quarter 2020 financial results on Thursday, Aug. 6, 2020. Bausch Health will host a conference... 
From PR Newswire
Sol-Gel Technologies Announces Agreements with Perrigo Company for Three New Generic Product Candidates
Generic Product Collaborations between the Companies Now Cover Ten Products 
From GlobeNewswire News Releases
Ortho Dermatologics Launches ARAZLO™ (tazarotene) Lotion, 0.045%, In The United States
Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses in the world, today announced that... 
From PR Newswire
BAUSCH + LOMB ULTRA® Silicone Hydrogel Contact Lenses Receive Approval In China
Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced that BAUSCH + LOMB ULTRA® monthly silicone hydrogel contact lenses... 
From PR Newswire
Bausch Health to Participate at Goldman Sachs Annual Leveraged Finance Conference
Bausch Health Companies Inc. (NYSE/TSX: BHC) today announced that Paul S. Herendeen, executive vice president and chief financial officer, Arthur J. Shannon, senior vice president and head of Investor... 
From PR Newswire
Salix Announces Inaugural Salix Gastrointestinal Health Scholars Program Recipients
$10,000 Scholarships Awarded to 10 Students Affected by GI Diseases 
From PR Newswire
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.